Detalhe da pesquisa
1.
Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial.
Lancet Infect Dis
; 22(10): 1472-1483, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772447